Search research articles
Contact Us
Filters
Showing results (51-60 of 231) with videos related to
Page
of 24
Sort By:
European Journal of Clinical Pharmacology
|
January 1, 1990
Pharmacokinetic study of methotrexate, folinic acid and their serum metabolites in children treated with high-dose methotrexate and leucovorin rescue
C Wolfrom, R Hepp, R Hartmann, et al.
Klinische Padiatrie
|
July 1, 1990
[Effect of 7S immunoglobulin substitution on the incidence and course of infection in cytostatic drug treated patients]
P Hadjilaskari, G Roehrig, R Hartmann, et al.
Scandinavian Journal of Immunology
|
August 29, 2012
The serotonin receptor-antagonist ondansetron induces significant increases in the expression of interferon-gamma which correlate with antiproliferative properties in the acute lymphoblastic leukaemia cell line REH
J Prada, S Shalapour, M Pfau, et al.
Klinische Padiatrie
|
March 1, 1979
[ALL therapy study 1971-1974 of the German working group for leukemia research and therapy in childhood: prognostic significance of initial features and different therapeutic modalities (author's transl)]
G Henze, H J Langermann, F Lampert, et al.
Leukemia
|
November 13, 2010
The sequence of application of methotrexate and histone deacetylase inhibitors determines either a synergistic or an antagonistic response in childhood acute lymphoblastic leukemia cells
L Bastian, H G Einsiedel, G Henze, et al.
Klinische Padiatrie
|
April 5, 2011
High reliability of scrotal ultrasonography in the management of childhood primary testicular neoplasms
G Tallen, P Hernáiz Driever, P Degenhardt, et al.
Bone Marrow Transplantation
|
November 1, 1996
Allogeneic BMT vs. chemotherapy in late bone marrow relapsed childhood non-T/non-B ALL: results of BFM ALL relapse studies. BFM Relapse Study Group
H Schmid, U von Schenck, R Hartmann, et al.
Haematology and Blood Transfusion
|
January 1, 1981
Treatment strategy for different risk groups in childhood acute lymphoblastic leukemia: A Report From the BFM Study Group
G Henze, H J Langermann, J Ritter, et al.
Haematology and Blood Transfusion
|
January 1, 1987
Therapy results in five ALL-BFM studies since 1970: implications of risk factors for prognosis
H Riehm, H J Feickert, M Schrappe, et al.
Leukemia & Lymphoma
|
June 1, 1993
Partial trisomy 1q, an uncommon chromosomal aberration in erythroleukemia
E Baumgarten, R D Wegner, R Fengler, et al.
Page
of 24
Search research articles
Search
Showing results (51-60 of 231) with videos related to
Sort By:
Page
of 24
European Journal of Clinical Pharmacology
|
January 1, 1990
Pharmacokinetic study of methotrexate, folinic acid and their serum metabolites in children treated with high-dose methotrexate and leucovorin rescue
C Wolfrom, R Hepp, R Hartmann, et al.
Klinische Padiatrie
|
July 1, 1990
[Effect of 7S immunoglobulin substitution on the incidence and course of infection in cytostatic drug treated patients]
P Hadjilaskari, G Roehrig, R Hartmann, et al.
Scandinavian Journal of Immunology
|
August 29, 2012
The serotonin receptor-antagonist ondansetron induces significant increases in the expression of interferon-gamma which correlate with antiproliferative properties in the acute lymphoblastic leukaemia cell line REH
J Prada, S Shalapour, M Pfau, et al.
Klinische Padiatrie
|
March 1, 1979
[ALL therapy study 1971-1974 of the German working group for leukemia research and therapy in childhood: prognostic significance of initial features and different therapeutic modalities (author's transl)]
G Henze, H J Langermann, F Lampert, et al.
Leukemia
|
November 13, 2010
The sequence of application of methotrexate and histone deacetylase inhibitors determines either a synergistic or an antagonistic response in childhood acute lymphoblastic leukemia cells
L Bastian, H G Einsiedel, G Henze, et al.
Klinische Padiatrie
|
April 5, 2011
High reliability of scrotal ultrasonography in the management of childhood primary testicular neoplasms
G Tallen, P Hernáiz Driever, P Degenhardt, et al.
Bone Marrow Transplantation
|
November 1, 1996
Allogeneic BMT vs. chemotherapy in late bone marrow relapsed childhood non-T/non-B ALL: results of BFM ALL relapse studies. BFM Relapse Study Group
H Schmid, U von Schenck, R Hartmann, et al.
Haematology and Blood Transfusion
|
January 1, 1981
Treatment strategy for different risk groups in childhood acute lymphoblastic leukemia: A Report From the BFM Study Group
G Henze, H J Langermann, J Ritter, et al.
Haematology and Blood Transfusion
|
January 1, 1987
Therapy results in five ALL-BFM studies since 1970: implications of risk factors for prognosis
H Riehm, H J Feickert, M Schrappe, et al.
Leukemia & Lymphoma
|
June 1, 1993
Partial trisomy 1q, an uncommon chromosomal aberration in erythroleukemia
E Baumgarten, R D Wegner, R Fengler, et al.
Page
of 24